SARS-CoV-2 Spike Protein Found in Long COVID Patients' Blood May Linger Up to One Year; What Implications Does This New Finding Suggest?

Medicine & Technology Sep 09, 2022

Study findings suggest the virus’s leftover reservoir could be stimulating the immune system which may fuel certain symptoms of long COVID. Read to know more.

Remdesivir Helps Alleviate Severe COVID-19 Symptoms; May Also Aid Against Protein That Contributes to Worsening Condition

Sep 28, 2021

Recent reports said Gilead Sciences Inc.'s remdesivir is keeping high-risk COVID-19 patients from getting admitted to the hospital.

Remdesivir Currently Being Modified from Intravenous to Oral Administration; Study Describes Potential of the Antiviral Drug in Treating COVID-19

Aug 04, 2021

Researchers are currently working to enhance Remdesivir, the only FDA-approved COVID-19 treatment. From being administered intravenously, it is currently being developed to be orally taken.

New COVID Study Shows Arthritis Drug, Baricitinib, Reduces Recovery Time for Adults

Dec 14, 2020

Hospitalized adults treated with an arthritis drug called baricitinib, in addition to COVID treatment programs, are found to recover faster, even in more serious cases of the highly contagious disease.

WHO Proposal vs FDA Recommendation: Doctors Should Not Use 'Remdesivir' As COVID-19 Treatment

Nov 20, 2020

Should doctors follow the World Health Organization or the US FDA?

Remdesivir Does Not Cut Hospital Days and Mortality on COVID-19 Patients, WHO Study Reveals

Oct 16, 2020

The results from WHO's Solidarity trial revealed that remdesivir has little to no effect on cutting the hospital days and mortality of COVID-19 patients.

Who is Gertrude Elion?

Aug 31, 2020

Gertrude Elion is the reason why today's medical experts have developed various types of drug treatments. Because of her work, scientists have been able to repurpose drugs and develop new treatments during the pandemic.

Yale Collaborates With AI Therapeutics for Potential COVID-19 Drug Treatment

Jul 28, 2020

Yale University alongside the pharmaceutical company AI Therapeutics looked into a drug that's been used to treat lymphoma disease. The team is also looking into combined treatment with remdesivir and hopes the drug will be an effective treatment for high-risk populations.

Scientists Are Working to Link Tuberculosis Vaccines and COVID-19

Jul 11, 2020

Tuberculosis vaccines may help reduce vulnerability to coronavirus and decrease mortality rates as well. Scientists are working on establishing a link between the Bacille Calmette-Guérin vaccine and Covid-19.

New York Lends a Helping Hand to Florida As Gov. Cuomo Sends Remdesivir to Coronavirus-Stricken State

Jul 11, 2020

New York Governor Andrew Cuomo is sending Florida a shipment of remdesivir to help its COVID-19 patients recover while the state waits on supplies from the federal government. The state has experienced a recent surge in cases, but its Governor, Ron DeSantis, denies help from other states.

Gilead Finally Releases Price for Esteemed Coronavirus Drug Remdesivir; Can People Afford It?

Jun 29, 2020

The price for remdesivir is out, and Gilead Sciences says it could cost up to $2,340 per patient for most wealthy nations. Some patient advocates contend that the price should be less, considering its development and trials received aid from the U.S. government. Click the link above to learn more.

Cipla Introduces Cipremi, Generic Remdesivir for COVID-19 Patients

Jun 22, 2020

Cipla Ltd., in partnership with Gilead Sciences, will soon manufacture generic versions of remdesivir in India. The drug will be under the brand name Cipremi, and the company hopes it would provide aid to all walks of life in the country.

Gilead’s Remdesivir Prevents Lung Damage in Monkeys, Adding to Its Long List of Successful Findings

Jun 09, 2020

Gilead's drug for coronavirus, remdesivir, once again shows its potential after a clinical trial reveals that it prevents lung damage in monkeys. Additionally, the results of the trial showed that the monkeys had minimal damage to their lungs in comparison with the control group.

Next on Gilead's Agenda: Inhaled Remdesivir and Other User-Friendly Versions of the Drug

Jun 03, 2020

Gilead Sciences just finished its phase 3 trials for remdesivir, and the results have been positive. As for the next step, the company seeks to explore making inhaled versions of the drug for early treatment of COVID-19 as well as easier treatment at home.

Montefiore and Einstein College Introduce Trials for Remdesivir-Baricitinib Combo as a Treatment Option for COVID-19

May 27, 2020

Montefiore Health System and Albert Einstein College of Medicine have begun with ACTT 2, a clinical trial using the drug combination remdesivir and baricitinib to treat patients with COVID-19. Researchers are hoping the new drug combo would reduce COVID-19-related inflammation and provide better recovery outcomes for coronavirus patients.